Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-02-02
1997-11-25
Rories, Charles C. P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
435 6, 4351723, 435366, 435375, 435377, 536 231, 536 2431, 536 2433, 536 245, 536 251, A61K 4800, C12N 510, C07H 2100, C12Q 168
Patent
active
056913176
ABSTRACT:
Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP-dependent protein kinases are disclosed along with pharmaceutical compositions containing these oligonucleotides as the active ingredients. These antisense oligonucleotides are useful for inhibiting the growth of cancer.
REFERENCES:
patent: 5087617 (1992-02-01), Smith
patent: 5097026 (1992-03-01), Jahnsen
patent: 5098890 (1992-03-01), Gewirtz et al.
patent: 5190931 (1993-03-01), Inouye
patent: 5271941 (1993-12-01), Cho-Chung
G. Carter et al., Br. J. Cancer 67 ('93) 869-76
K. Brigham et al. Am. J. Med. Sci. 298 (4) (Oct. 1989) 278-81.
E. Uhlmann et al., Chemical Reviews, vol. 90 (4) ('90) pp. 543-584.
S. Crooke, Annu. Rev. Pharmacol. Toxicol., vol. 32 ('92), 329-76.
A. van der Krol et al., BioTechniques, vol. 6 (10) ('88) pp. 958-976.
M. Sandberg et al., Bioch. Biophys. Res. Comm., vol. 149 (3) ('87) 939-945.
Y. Cho-Chung, J. NCI, vol. 81 (13) ('89) pp. 982-987.
J. Wermur, Crit. Rev. in Biochem & Mol. Biol., 26 (3/4) ('91) 227-259.
Ally, S. et al., "Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3',5'-cyclic monophosphate provides a biological means for control of human colon cancer cell growth," Proc. Natl. Acad. Sci. USA 85:6319-6322 (1988).
Becker, D. et al., "Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor," EMBO J. 8(12):3685-3691 (1989).
Beebe, S. J. and Corbin, J. D., "Cyclic Nucleotide-Dependent Protein Kinases," in: The Enzymes, vol. XVII, part A, San Diego: Academic Press, Inc., pp. 43-111 (1986).
Campbell, J. M. et al., "Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid," J. Biochem. Biophys. Meth. 20(3):259-267 (Mar. 1990).
Cho-Chung, Y. S. et al., "Site-Selective Cyclic AMP Analogs as New Biological Tools in Growth Control, Differentiation, and Proto-oncogene Regulation," Canc. Invest. 7(2):161-177 (1989).
Cho-Chung, Y. S. et al., "A RI.alpha. subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase blocks proliferation in human and rodent cancer cell lines by-passing exogenous cAMP effect," Proc. Am. Assoc. Canc. Res. 31:29 Abstract No. 171 (Mar. 1990).
Clair, T. et al., "An antisense oligodeoxynucleotide targeted against the type I regulatory subunit (RI.alpha.) mRNA of cAMP-dependent protein kinase (PKA) inhibits the growth of LS-174T human colon carcinoma in athymic mice," Proc. Am. Assoc. Cancer Res. 32:277 Abs. 1645 (Mar. 1991).
Clegg, C. H. et al., "Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase," Proc. Natl. Acad. Sci. USA 85:3703-3707 (1988).
Cohen, J. S., "Designing antisense oligonucleotides as pharmaceutical agents," Trends Pharmacol. Sci. 10(11):435-437 (1989).
Cohen, J. S., "Introduction: Strategies and Realities," in: Topics in Molecular and Structural Biology: Oligodeoxynucleotides: Antisense Inhibitors of Gene Expression, J. S. Cohen, ed., Boca Raton, Fla.: CRC Press, Inc., pp. 1-6 (1989).
Corbin, J. D. et al., "The Distribution and Dissociation of Cyclic Adenosine 3':5'-Monophosphate-dependent Protein Kinases in Adipose, Cardiac, and Other Tissues," J. Biol. Chem. 250(1):218-225 (1975).
DeVita, Jr., V. T., "Principles of Chemotherapy," in: Cancer Principles & Practice of Oncology, V. T. DeVita, Jr. et al., eds., Philadelphia: J.B. Lippincott Co., pp. 257-285 (1985).
Furukawa, Y. et al., "cdc2 Gene Expression at the G.sub.1 to S Transition in Human T Lymphocytes," Science 250:805-808 (Nov. 1990).
Guadagni, F. et al., "Regulation of Carcinoembryonic Antigen Expression in Different Human Colorectal Tumor Cells by Interferon-.gamma.," Canc. Res. 50:6248-6255 (Oct. 1990).
Guadagni, F. et al., "Carcinoembryonic Antigen Regulation in Human Colorectal Tumor Cells by a Site-Selective Cyclic AMP Analogue: A Comparison with Interferon-gamma," Int. J. Canc. 48(3):413-422 (May 1991).
Heywood, S. M., "tcRNA as a naturally occurring antisense RNA in eukaryotes," Nucl. Acids Res. 14(16):6771-6772 (1986).
Hofmann, F. et al., "Concentrations of Cyclic AMP-dependent Protein Kinase Subunits in Various Tissues," J. Biol. Chem. 252(4):1441-1447 (1977).
Iversen, P., "In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue," Anti-Canc. Drug Design 6(6):531-538 (Dec. 1991).
Iyer, R. P. et al., "3H-1,2-Benzodithiole-3-one 1,1-Dioxide as an Improved Sulfurizing Reagent in the Solid-Phase Synthesis of Oligodeoxyribonucleoside Phosphorothioates," J. Am. Chem. Soc. 112(3):1253-1254 (Jan. 1990).
Jahnsen T. et al., "Molecular Cloning, cDNA Structure, and Regulation of the Regulatory Subunit of Type II cAMP-dependent Protein Kinase from Rat Ovarian Granulosa Cells," J. Biol. Chem. 261(26):12352-12361 (1986).
Jaroszewski, J. W. et al., "Concerning Antisense Inhibition of the Multiple Drug Resistance Gene," Canc. Commun. 2(8):287-294 (Aug. 1990).
Jaskulski, D. et al., "Inhibition of Cellular Proliferation by Antisense Oligodeoxynucleotides to PCNA Cyclin," Science 240:1544-1546 (1988).
Katsaros, D. et al., "Site-Selective cyclic AMP analogs provide a new approach in the control of cancer cell growth," FEBS Letts. 223(1):97-103 (1987).
Lee, D. C. et al., "Isolation of a cDNA clone for the type I regulatory subunit of bovine cAMP-dependent protein kinase," Proc. Natl. Acad. Sci. USA 80:3608-3612 (1983).
Levy, F. O. et al., "Molecular Cloning, Complimentary Deoxyribonucleic Acid Structure and Predicted Full-Length Amino Acid Sequence of the Hormone-Inducible Regulatory Subunit of 3'-5'-Cyclic Adenosine Monophosphate-Dependent Protein Kinase from Human Testis," Mol. Endo. 2(12):1364-1373 (1988).
Milligan, J. F. et al., "Current Concepts in Antisense Drug Design," J. Med. Chem. 36(14):1923-1937 (1993).
Mirabelli, C. K. et al., "In vitro and in vivo pharmacologic activities of antisense oligonucleotides," Anti-Canc. Drug Design 6(6):647-661 (Dec. 1991).
Mizuno, T. et al., "A unique mechanism regulating gene expression: Translational inhibition by a complementary RNA transcript (micRNA)," Proc. Natl. Sci. USA 81:1966-1970 (1984).
.O slashed.gried, D. et al., "Activation of protein kinase isozymes by cyclic nucleotide analogs used singly or in combination: Principles for optimizing the isozyme specificity of analog combinations," Eur. J. Biochem. 150:219-227 (1985).
.O slashed.yen, O. et al., "Human Testis cDNA for the regulatory subunit RII.sub..alpha. of cAMP-dependent protein kinase encodes an alternate amino-terminal region," FEBS Letts. 246(1.2):57-64 (1989).
Paterson, B. M. et al., "Structural gene identification and mapping by DNA.cndot.mRNA hybrid-arrested cell-free translation," Proc. Natl. Acad. Sci. USA 74(10):4370-4374 (1977).
Perlaky, L. et al., "Growth inhibition of human tumor cell lines by antisense oligonucleotides designed to inhibit p120 expression," Anti-Canc. Drug Design 8:3-14 (1993).
Phillips, R. M. et al., "A Critical Appraisal of the Predictive Value of In Vitro Chemosensitivity Assays," J. Natl. Canc. Inst. 82(18):1457-1468 (Sep. 1990).
Potera, C., "`Reverse Transformation` Studies Provide Clues for Treating Malignancies," Genet. Eng. News 5(8):20 (1985).
Potts, J. D. et al., "Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor .beta.3," Proc. Natl. Acad. Sci. USA 88:1516-1520 (Feb. 1991).
Ratajczak, M. Z. et al., "In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides," Proc. Natl. Acad. Sci. USA 89:11823-11827 (1992).
Robinson-Steiner, A. M. and Corbin, J. D., "Probable Involvement of Both Intrachain cAMP Binding Sites in Activation of Protein Kinase," J. Biol. Chem. 258(2):1032-1040 (1983).
Schwartz, D. A. and Rubin, C. S., "Identification and Differential Expression of Two Forms of Regulatory Subunits (RII) of cAMP-dependent Protein Kinase II in Friend Erythroleukemic Cells: Differentiation and 8-bromo-cAMP Elicit a Large
LandOfFree
Antisense oligonucleotides of human regulatory subunit RI-alpha does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides of human regulatory subunit RI-alpha , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides of human regulatory subunit RI-alpha will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107183